|
|
Volumn 14, Issue 3, 2008, Pages 380-384
|
|
Preemptive treatment of fungal infection: Has its time arrived in liver transplantation?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 1,3 GLUCAN;
COTRIMOXAZOLE;
FLUCONAZOLE;
GALACTOMANNAN;
GLUCOSE;
INSULIN;
ASPERGILLOSIS;
ASPERGILLUS FUMIGATUS;
CANDIDA;
CANDIDIASIS;
CELL WALL;
CEPHALOSPORIUM;
CHEMOPROPHYLAXIS;
CLINICAL EFFECTIVENESS;
CRYPTOCOCCUS NEOFORMANS;
DRUG RESPONSE;
FOLLOW UP;
FUNGUS CULTURE;
FUSARIUM;
GASTROINTESTINAL TOXICITY;
GRAFT RECIPIENT;
HIGH RISK PATIENT;
HUMAN;
IMMUNOASSAY;
KIDNEY DYSFUNCTION;
LIVER GRAFT;
LIVER TRANSPLANTATION;
LIVING DONOR;
MORTALITY;
MYCOSIS;
PATIENT MONITORING;
PENICILLIUM;
PNEUMOCYSTIS JIROVECI;
PNEUMOCYSTIS PNEUMONIA;
POSTOPERATIVE INFECTION;
PREDICTION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
SENSITIVITY AND SPECIFICITY;
SHORT SURVEY;
TRICHOSPORON;
AGING;
BLOOD GLUCOSE MONITORING;
BOLUS INJECTION;
CONTINUOUS INFUSION;
CRITICALLY ILL PATIENT;
DISEASE ASSOCIATION;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
GRAFT SURVIVAL;
HYPERGLYCEMIA;
INCIDENCE;
INFECTION RATE;
INSULIN TREATMENT;
INTENSIVE CARE UNIT;
PEROPERATIVE COMPLICATION;
RETROSPECTIVE STUDY;
RISK REDUCTION;
|
|
EID: 41149087227
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.21438 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (3)
|
